0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $2,000 | January 2024
    Product Insights

    Myocardial Ischemia – Drugs In Development, 2023

    Global Markets Direct’s, ‘Myocardial Ischemia - Drugs In Development, 2023’, provides an overview of the Myocardial Ischemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocardial Ischemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Atrial Fibrillation – Drugs In Development, 2023

    Global Markets Direct’s, ‘Atrial Fibrillation - Drugs In Development, 2023’, provides an overview of the Atrial Fibrillation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atrial Fibrillation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pancreatic Diseases – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pancreatic Diseases - Drugs In Development, 2023’, provides an overview of the Pancreatic Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pancreatitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pancreatitis - Drugs In Development, 2023’, provides an overview of the Pancreatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Atherosclerosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Arteriosclerosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Arteriosclerosis - Drugs In Development, 2023’, provides an overview of the Arteriosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arteriosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Ischemic Stroke – Drugs In Development, 2023

    Global Markets Direct’s, ‘Ischemic Stroke - Drugs In Development, 2023’, provides an overview of the Ischemic Stroke pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ischemic Stroke, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $100 | November 2023
    Product Insights

    Verbois

    Verbois is a Hydro project located in Geneva, Switzerland. The project is owned by Services Industriels de Geneve. The project came online in 1944. Empower your strategies with our Verbois report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...

  • Company Insights

    $1,295 | September 2023
    Company Insights

    Pictet Group – Competitor Profile

    Pictet Group Competitor Profile Overview Headquartered in Geneva, Switzerland, Pictet Group is a corporate partnership offering wealth management and investment services in Europe, Asia, the Americas, and the Middle East. The group has 30 offices in 19 countries around the world. It has four divisions: Asset Management, Wealth Management, Alternative Advisors, and Asset Services. The Pictet Group competitor profile report comprehensively analyzes Pictet Group's private banking operations. It offers insights into the company’s strategy and financial performance, including key data...

  • Product Insights

    New
    $4,000 | February 2024
    Product Insights
    New

    Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

    Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.